Masimo (MASI)
(Delayed Data from NSDQ)
$106.34 USD
-0.99 (-0.92%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $106.25 -0.09 (-0.08%) 4:56 PM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
MASI 106.34 -0.99(-0.92%)
Will MASI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MASI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MASI
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View
MASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Top Estimates
Intuitive Surgical (ISRG) Q2 Earnings Beat, Procedures Robust
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
Other News for MASI
New Study Finds That Remote Patient Monitoring with Masimo SafetyNet? Significantly Reduced Rates of Hospital Readmission and ED Visits for Patients Recuperating at Home After Joint Replacement Surgery
Masimo: SafetyNet RPM reduces readmission and ED visits post surgery
Masimo to Report Second Quarter 2024 Financial Results After Market Close on Tuesday, August 6
3 Healthcare Stocks to Buy Now: Q3 Edition
Masimo Corporation: A Bitter Proxy Fight Hurts The Shares